New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
LiveWire Ergogenics, Inc.
LVVV
Shape
US Flag

PNK

1M

Drug Manufacturers - Specialty & Generic

Next Earning date - 18 Nov 2024

1M

Drug Manufacturers - Specialty & Generic

Next Earning date - 18 Nov 2024

0.00USD
0.00 ( 0.00%)
Market Open
favorite-chart

Relative Strenght

favorite-chart

Volume Buzz

394%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

100%

Quote Panel

Shape
Updated October 24, 2024
1W -5.26 % 1M -14.29 % 3M -45.45 % 1Y -80.00 %

Key Metrics

Shape
  • Market Cap

    1.36M


  • Shares Outstanding

    1.51B


  • Share in Float

    1.51B


  • Dividende

    0


  • Earning Date

    18 Nov 2024


  • Price Target

    0.0009


  • Average Volume

    1.26M


  • Beta

    1.098


  • Range

    8.0E-4-0.0045


  • Industry

    Drug Manufacturers - Specialty & Generic


  • Website

    https://livewireergogenics.com


  • Sector

    Healthcare


Fundamentals

Shape

7.50x

P/E Ratio

1.24x

P/S Ratio

0.50x

P/B Ratio

1.0

Debt/Equity

55.6%

Net Margin

$-0.0

EPS

How LVVV compares to sector?

P/E Ratio

Relative Strength

Shape

LVVV

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

No Data Available

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q2.22

arrow
arrow

N/A

NA
vs NA

Q3.22

arrow
arrow

N/A

NA
vs NA

Q4.22

arrow
arrow

N/A

NA
vs NA

Q1.23

arrow
arrow

N/A

NA
vs NA

Q2.23

arrow
arrow

N/A

NA
vs NA

Q3.23

arrow
arrow

N/A

NA
vs NA

Q4.23

arrow
arrow

N/A

0
vs NA

Q1.24

arrow
arrow

N/A

NA
vs NA

Q2.24

arrow
arrow

N/A

NA
vs NA

Q3.24

arrow
arrow

N/A

1.54
vs NA

Sales GrowthShape

status-upYoY

Current

Estimates

Q2.22

arrow
arrow

+323%

463.3K  vs 109.5K

Q3.22

arrow
arrow

+51%

378.5K  vs 250.2K

Q4.22

arrow
arrow

+68%

687.7K  vs 408.5K

Q1.23

arrow
arrow

-7%

378.5K  vs 408.5K

Q2.23

arrow
arrow

-22%

363.5K  vs 463.3K

Q3.23

arrow
arrow

+45%

547.8K  vs 378.5K

Q4.23

arrow
arrow

-50%

343.9K  vs 687.7K

Q1.24

arrow
arrow

-68%

121.8K  vs 378.5K

Q2.24

arrow
arrow

-77%

84.7K  vs 363.5K

Q3.24

arrow
arrow

-83%

93.7K  vs 547.8K

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

+3%

0.03
vs 0.14

Q4.22

arrow
arrow

+22%

0.22
vs 0.03

Q1.23

arrow
arrow

+8%

0.08
vs 0.22

Q2.23

arrow
arrow

+9%

0.09
vs 0.08

Q3.23

arrow
arrow

+9%

0.09
vs 0.09

Q4.23

arrow
arrow

+8%

0.08
vs 0.09

Q1.24

arrow
arrow

+2%

0.02
vs 0.08

Q2.24

arrow
arrow

+1%

0.01
vs 0.02

Institutionnal OwnershipShape

status-upQoQ

Q1.19

arrow
arrow

1

1
vs NA

NA

Q2.19

arrow
arrow

1

1
vs 1

NA

Q3.19

arrow
arrow

1

1
vs 1

NA

Earnings Growth

Latest News